This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
PD-1/PD-L1 binding studies using microscale thermophoresis
Scientific Reports Open Access 15 December 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Cautious optimism surrounds early clinical data for PD-1 blocker. Nat Biotechnol 30, 729–730 (2012). https://doi.org/10.1038/nbt0812-729
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0812-729
This article is cited by
-
PD-1/PD-L1 binding studies using microscale thermophoresis
Scientific Reports (2017)
-
First PD-1 inhibitor breezes across finish line
Nature Biotechnology (2014)
-
Industry pursues co-stimulatory receptor immunomodulators to treat cancer
Nature Biotechnology (2013)
-
Melanoma combination therapies ward off tumor resistance
Nature Biotechnology (2013)